The purpose of this trial is to study the effects of preoperative antithrombin supplementation in patients undergoing cardiac surgery with cardiopulmonary bypass in order to maintain antithrombin levels in a range greater than 58% of functional activity and, eventually, to decrease negative clinical outcomes during the ICU stay.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Postoperative ATIII Levels at the ICU Admission
Timeframe: ICU admission
Percentage of Subjects With ATIII Levels of 58% or Higher at ICU Admission
Timeframe: ICU admission